Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MFF pseudogene 1 is a pseudogene related to the mitochondrial fission factor gene, located on human chromosome 1, 5, or X[1][2]. Pseudogenes like MFFP1 arise from duplication or retrotransposition events but are mutated such that they do not encode functional proteins. While some pseudogenes are transcribed and can play regulatory roles in rare cases (e.g., through RNA-based mechanisms), most—including MFF pseudogene 1—are not known to have active biological functions or disease associations[3][4][5]. Thus, MFFP1 is not considered a therapeutic or diagnostic target. If you are seeking information on a functional drug or research target, consider the mitochondrial fission factor gene/protein (MFF) itself, not its pseudogenes[1][2]. There is no evidence in current literature or databases that MFF pseudogene 1 is a drug target, biomarker, or plays any established biological or clinical role.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MFF pseudogene 1 (MFFP1).